1.
Xing L, He Q, Xie L, Wang H, Li Z. Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review. haematol [Internet]. 2021Dec.23 [cited 2022Oct.6];107(5):1226-8. Available from: https://haematologica.org/article/view/haematol.2021.280259